US OptionsDetailed Quotes
AZN241108P78000
- 3.20
- 0.000.00%
15min DelayTrading Oct 25 12:58 ET
0.00High0.00Low
0.00Open3.20Pre Close0 Volume507 Open Interest78.00Strike Price0.00Turnover0.00%IV-15.76%PremiumNov 8, 2024Expiry Date13.39Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.84Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AstraZeneca Stock Discussion
Sign in to post a comment
$AstraZeneca (AZN.US)$
astra not woke up yet in usa 😂😂😂, but in uk, share price going down 😂😂😂
astra not woke up yet in usa 😂😂😂, but in uk, share price going down 😂😂😂
2
$Bright Minds Biosciences (DRUG.US)$ volatility moving to $Monopar Therapeutics (MNPR.US)$ instead. $AstraZeneca (AZN.US)$ owns 10% of it buy!!
1
2
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
22 above today
$Conduit Pharmaceuticals (CDT.US)$ just to let you know, astrazeneca has a big part of this stock! $AstraZeneca (AZN.US)$
1
Chinese Stocks Surge on Return from Holidays as Euphoria Extends [CSOP Global Market Morning Report]
【China】
🔸 Chinese Stocks Surge on Return from Holidays as Euphoria Extends. Chinese stocks listed onshore jumped as trading resumed following a week-long holiday, with encouraging home sales and consumption data giving fresh impetus to a rally sparked by Beijing’s stimulus blitz. The benchmark CSI 300 Index and SSEC Index climbed almost 11% in early trading before paring its advance. The measure h...
🔸 Chinese Stocks Surge on Return from Holidays as Euphoria Extends. Chinese stocks listed onshore jumped as trading resumed following a week-long holiday, with encouraging home sales and consumption data giving fresh impetus to a rally sparked by Beijing’s stimulus blitz. The benchmark CSI 300 Index and SSEC Index climbed almost 11% in early trading before paring its advance. The measure h...
![Chinese Stocks Surge on Return from Holidays as Euphoria Extends [CSOP Global Market Morning Report]](https://ussnsimg.moomoo.com/sns_client_feed/71451441/20241008/1728367312428-c514003b5c.jpeg/thumb?area=999&is_public=true)
2
$AstraZeneca (AZN.US)$
FDA Approves Osimertinib For Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer After Chemoradiation Therapy; Recommended Dose Is 80mg Daily Until Disease Progression Or Unacceptable Toxicity
FDA Approves Osimertinib For Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer After Chemoradiation Therapy; Recommended Dose Is 80mg Daily Until Disease Progression Or Unacceptable Toxicity
1
The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
+7
75
9
No comment yet
defishu :![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Low enough, right?
102875548 OP defishu : AstraZeneca shares fall as China probe intensifies
astra fell 8% in UK market